Sunday, November 8, 2026

Back to the front page

Vicor Update, Part Four

Vicor’s Federal Circuit hearing put Foxconn’s disputed patent license under pressure, reinforcing its AI server royalty model and licensing leverage.

From X

@AsifSuria

Asif Suria on X

Nike's stock $NKE is down almost an additional 10% since I wrote this in June and what is even more remarkable is that On Holding $ONON is down 31% over the last year. The company went public on September 15, 2021 at $24 per share and closed its first day of trading at $35. All the wins On Running had against Nike, didn't matter because the starting valuation the market afforded the company towards the tail end of the COVID-19 bull market was too high. I have a pair of On shoes and had almost forgotten how remarkably comfortable they are until I switched to an older pair of Asics for a day. Ever since my Skechers shares were acquired by the PE firm 3G Capital last year, I have been thinking about investing in a potential turnaround at Nike or betting on $ONON's growth but thankfully decided against either option. Decker's $DECK with its HOKA and UGG brands hasn't been too hot either, down 14% over the last year. The correct move would have been $CROX or Asics in the Japanese market. But that is hindsight bias. Looking forward, two insiders, including the Co-CEO of $ONON appear to be bullish about the company's future prospects and purchased $2 million worth of stock each according to a Form 4 filed yesterday. The same insiders including the other Co-CEO also purchased shares in May at higher prices. Insiders are often early and that could certainly be the case here but these purchases are making me take a fresh look at $ONON again.

Floor & Decor 3Q26: Business Update

Floor & Decor’s 3Q26 sales rose 3% while comparable sales fell 1.4%; it cut 2027 openings to 10-15 as high mortgage rates pressure…

MTMTY · short

Metlen Energy & Metals PLC

Metlen Energy & Metals faces a 40% short case centered on its overpriced aluminium, alumina and Greek power businesses.

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.